Results 51 to 60 of about 800,932 (208)

Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra [PDF]

open access: yes, 2007
Population surveys for niacin deficiency are normally based on clinical signs or on biochemical measurements of urinary niacin metabolites. Status may also be determined by measurement of whole blood NAD and NADP concentrations. To compare these methods,
Cheung, E   +5 more
core   +2 more sources

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

open access: yesHepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger   +7 more
wiley   +1 more source

Ezetimibe therapy: mechanism of action and clinical update. [PDF]

open access: yes, 2012
The lowering of low-density lipoprotein cholesterol (LDL-C) is the primary target of therapy in the primary and secondary prevention of cardiovascular events.
Dayspring, Thomas D   +2 more
core   +1 more source

Dietary assessment methods for micronutrient intake in elderly people: a systematic review [PDF]

open access: yes, 2009
The European micronutrient recommendations aligned (EURRECA) Network of Excellence seeks to establish clear guidelines for assessing the validity of reported micronutrient intakes among vulnerable population groups.
Doreste-Alonso, J.   +5 more
core   +2 more sources

Association of niacin intake with constipation in adult: result from the National Health and Nutrition Examination

open access: yesEuropean Journal of Medical Research, 2023
Background Although dietary intake is believed to be associated with constipation, there is currently a lack of research exploring the relationship between niacin intake and constipation. Therefore, the aim of this study is to investigate the association
Xiao Huang   +5 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value

open access: yesFrontiers in Nutrition, 2023
BackgroundThe PNPLA3 p.I148M impact on fat accumulation can be modulated by nutrients. Niacin (Vitamin B3) reduced triglycerides synthesis in in vitro and in vivo NAFLD models.ObjectivesIn this study, we aimed to investigate the niacin-I148M polymorphism
Erika Paolini   +14 more
doaj   +1 more source

P255 Dietary niacin intake is inversely associated with the development of gallstones: a prospective cohort study

open access: yesPosters, 2021
Introduction Dietary niacin may prevent gallstones, a major cause of acute pancreatitis (AP), by increasing plasma high density lipoprotein and lowering triglycerides, both associated with reduced rates of gallstones.
H. Lim   +3 more
semanticscholar   +1 more source

Association between niacin and mortality among patients with cancer in the NHANES retrospective cohort

open access: yesBMC Cancer, 2022
Background The vitamin niacin is used as a lipid-regulating supplement, but it is unknown whether niacin has a positive influence on cancer prognosis.
Hongan Ying   +5 more
doaj   +1 more source

Niacin – a scoping review for Nordic Nutrition Recommendations 2023

open access: yesFood & Nutrition Research, 2023
Niacin is the precursor to pyridine nucleotides NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleotide phosphate). Niacin (vitamin B3) is the common term for nicotinic acid, nicotinamide and derivatives that exhibit the ...
Riitta Freese, Vegard Lysne
doaj   +1 more source

Home - About - Disclaimer - Privacy